Endocrinology / diabetes clinical trials recruiting in Pennsylvania

298 recruiting endocrinology / diabetes trials match in Pennsylvania. Showing 20.

• A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerRecruiting

  Phase 3 · Hoffmann-La Roche · Pittsburgh, Pennsylvania

• BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)Recruiting

  Phase 1 / Phase 2 · BioInvent International AB · Philadelphia, Pennsylvania

• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinRecruiting

  Phase 3 · Eli Lilly and Company · Pittsburgh, Pennsylvania

• A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' DiseaseRecruiting

  Phase 2 · Immunovant Sciences GmbH · Pottstown, Pennsylvania

• Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Recruiting

  Phase 2 · Sparrow Pharmaceuticals · West Chester, Pennsylvania

• A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusRecruiting

  Phase 3 · AstraZeneca · St Leonards

• WellSpan-THRIVE Cancer QOL StudyRecruiting

  N/A · WellSpan Health · Chambersburg, Pennsylvania

• Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATGRecruiting

  Phase 2 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Pittsburgh, Pennsylvania

• Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM MetricsRecruiting

  N/A · Milton S. Hershey Medical Center · Pittsburgh, Pennsylvania

• Monitoring Eating Across Locations (MEAL) - Timing, Intake, and Mealtime Evaluation (TIME)Recruiting

  N/A · Penn State University · State College, Pennsylvania

• Beta-cell Response to Incretin Hormones in Cystic FibrosisRecruiting

  N/A · University of Pennsylvania · Philadelphia, Pennsylvania

• Signatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerRecruiting

  N/A · Natera, Inc. · Greenbrae, California

• Empagliflozin Treatment in Kidney Transplant RecipientsRecruiting

  Phase 4 · VA Office of Research and Development · Pittsburgh, Pennsylvania

• Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Recruiting

  Phase 3 · NRG Oncology · Allentown, Pennsylvania

• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsRecruiting

  Phase 1 · IDEAYA Biosciences · Philadelphia, Pennsylvania

• DFC 004 Biomarkers for Active Diabetic Foot UlcersRecruiting

  N/A · University of Michigan · Pittsburgh, Pennsylvania

• An Acceptance-Based Healthy Lifestyle Intervention for Diverse AdolescentsRecruiting

  N/A · Nemours Children's Clinic · Philadelphia, Pennsylvania

• Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic FistulaRecruiting

  Phase 3 · SWOG Cancer Research Network · Allentown, Pennsylvania

• FTT PET/CT in Pancreatic Neuroendocrine TumorsRecruiting

  Phase 1 · Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania

• Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic CancerRecruiting

  Phase 1 / Phase 2 · National Cancer Institute (NCI) · Pittsburgh, Pennsylvania

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.